RUTW241203C2185000
- 0.00
- 0.000.00%
Russell 2000 Index Newsroom
How Is The Market Feeling About Carpenter Tech?
(PFSI) - Analyzing PennyMac Financial Servs's Short Interest
Northland Capital Markets Maintains Outperform on Honest Co, Raises Price Target to $9.5
Honest Co Analyst Ratings
This Pure Storage Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
Northland Capital Markets Maintains Outperform on Cipher Mining, Raises Price Target to $8.5
Cipher Mining Analyst Ratings
DocGo Announced That Its Cardiac RMS Subsidiary Has Signed A New Contract With One Of The Largest Hospital Systems In Mississippi
Daktronics Continues To Expect Order Volume To Increase For The Full Fiscal Year
Daktronics Q2 Product Order Backlog $236.0M As Of October 26, 2024
Daktronics Beats Top-line and Bottom-line Estimates; Reaffirms FY25 Outlook
HC Wainwright & Co. Reiterates Buy on MARA Holdings, Maintains $28 Price Target
MARA Holdings Analyst Ratings
Market-Moving News for December 4th
Brookline Bancorp Analyst Ratings
Foot Locker Analyst Ratings
Wall Street's Most Accurate Analysts Spotlight On 3 Industrials Stocks With Over 5% Dividend Yields
Keefe, Bruyette & Woods Downgrades Hanmi Financial to Market Perform, Raises Price Target to $29
The year marks a turning point for iPhone, what does it mean for the supply chain?
Nomura believes that this year's iPhone 16 series is not fully adapted for AI applications in terms of hardware, and the iPhone 17 series to be launched in the second half of next year may be Apple's first true AI phone, at which point Apple may re-adjust its product line. It is expected that the iPhone 17 series will be equipped with the A19 series processor, with upgrades in screen size, pixels, and memory. The Pro series may switch to aluminum alloy material for the body, and additional heat dissipation components may be added.
Atea Pharmaceuticals Announced That The Company's Phase 2 Study Of The Regimen Of Bemnifosbuvir, A Nucleotide Analog Polymerase Inhibitor, And Ruzasvir, An Ns5a Inhibitor, For Treatment Of Hepatitis C Virus Met Its Primary Endpoints Of Safety And...